Red Cross Hospital Beverwijk Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT00881088
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Embolism (Phase 3)

Pulmonary Embolism (Phase 3)

Thrombosis (Phase 3)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 5